Luteinizing hormone releasing hormone agonists and antagonists: Current status

Current Opinion in Drug Discovery and Development

Volumn 3, Issue 2, 2000, Pages 244-249

  Petousis, Nikolaos H ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

GnRH; Gonadotropin; LHRH agonists; LHRH antagonists

Indexed keywords

ABARELIX; BUSERELIN; CETRORELIX; DETIRELIX; GANIRELIX; GONADORELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GOSERELIN; HISTRELIN; ITURELIX; LEUPRORELIN; LUTRELIN; NAFARELIN; TRIPTORELIN;

DRUG MECHANISM; DRUG SYNTHESIS; HORMONAL REGULATION; HORMONE INHIBITION; HORMONE STRUCTURE; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; REGULATORY MECHANISM; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0033995758     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Schally AV, McCann SM, The privileges of a Nobel laureate. Fertil Steril (1995) 64:452-453.
2. Schally AV, Arimura A, Kastin AJ, Matsuo H, Baba Y, Redding TW, Nair RM, Debeljuk L, White WF, Gonadotropin-releasing hormone: One polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science (1971)173:1036-1038.
3. Filicori M, Flamigni C, GnRH agonists and antagonists. Current clinical status. Drugs (1988) 35:63-82.
4. Fräser HM, GnRH and its analogues. Current therapeutic applications and new prospects. Drugs (1984) 27:187-193.
5. Goulet MT, Gonadotropin-releasing hormone antagonists. Annu Rep Med Chem (1995) 30:169-178.
6. Reissmann T, Felberbaum R, Diedrich K, Engel J, ComaruSchaliy AM, Schally AV, Development and applications of luteinizing hormone-releasing hormone antagonists In the treatment of infertility: An overview. Hum Reprod (1995) 10:1974-1981.
7. Funk KW, Gréer J, Pharmaceutical biotechnology. In: Integration of Pharmaceutical Discovery and Development: Case Studies. Borchardt RT, Freidinger RM, Sawyer TK, Smith PL (Eds), Plenum Press, NY (1998) 11:151-183.
8. Karten MJ, Rivier JE, Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: Rationale and perspective. Endocr Rev (1986) 7:44-66.
9. Barbieri RL, Clinical applications of GnRH and its analogues. Trends Endocrinol Metab (1992) 3:30-34.
10. Schmidt R, Sundaram K, Thau RB, Bardin CW: [Ac-D-NAL(2)', 4FD-Phe3,D-Trp',D-Arg>]-LHRH, a potent antagonist of LHRH, produces transient edema and behavioral changes in rats. Contraception (1984) 29:283-289.
11. Bajusz S, Csemus VJ, Janaky T, Bokser L, Fekete M, Schally AV, New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues. Int J Pept Protein Res (1988) 32:425-435.
12. Kutscher B, Bernd M, Bäckers T, Polymeropoulos EE, Engel J, Chemistry and molecular biology in the search for new LHRH antagonists. Angew Chem Int Ed Engl (1997) 36:2148-2161.
13. Graul A, Rabasseda X, Castaner J, Abarelix. Drugs Future (1998)23:1057-1061.
14. Ljungqvist A, Feng DM, Hook W, Shen ZX, Bowers C, Folkers K, Antide and related antagonists of luteinizing hormone release with long action and oral activity. Proc Natl Acad Sci USA (1988) 85:8236-8240.
15. Nestor JJ, Tahilramani R, Ho TL, Goodpasture JC, Vickery BH, Ferrandon P, Potent gonadotropin releasing hormone antagonists with low histamine-releasing activity. J Med Chem (1992) 35:3942-3948.
16. Bajusz S, Csemus VJ, Janaky T, Bokser L, Fekete M, Serially AV, New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues. Int J Pept Protein Res (1988) 32:425-435.
17. Reissmann TH, Engler J, Centrorelix, a potent LHRHantagonist: Chemistry, pharmacology and clinical data. In: Peptides and Biological Chemistry Proceedings of the Chinese Peptide Symposium. Xu X-J, Ye Y-H, Tarn J (Eds), Kluwer Academic Publishers, The Netherlands (1998) 4:142-146.
18. Rivier JE, Jiang G, Porter J, Hoeger CA, Craig AG, Corrigan A, Vale W, Rivier CL, Gonadotropin-releasing hormone antagonists: Novel members of the azaline B family. J Med Chem (1995) 38:2649-2662.
19. Haviv F, Fitzpatrick TD, Nichols CJ, Bush EN, Diaz G, Bammert G, Nguyen AT, Johnson ES, Knittle J, Gréer J, In vitro and in vivo activities of reduced-size antagonists of luteinizing hormone-releasing hormone. J Med Chem (1994) 37:701-705.
20. Cho N, Harada M, Imaeda T, Imada T, Matsumoto H, Hayase Y, Sasaki S, Furuya S, Suzuki N, Okubo S, Ogi K, Endo S, Onda H, Fujino M, Discovery of a novel, potent, and orally active non-peptide antagonist of the human luteinizing hormone-releasing hormone (LHRH) receptor. J Med Chem (1998)41:4190-4195.
21. Fauser BC, Endocrinological findings during treatment with ganirelix (orgalutran). Gynecol Endocrinol (1999) 13(Suppl1):Abs025.
22. TAKEDA CHEMICAL INDUSTRIES LTD (Furuya S, Choh N, Kalo K, Hinuma S), Bicyclic thiophene derivatives and use as gonadotropin releasing hormone antagonists. WO- 09528405 (1995).
23. TAKEDA CHEMICAL INDUSTRIES LTD (Kalo K, Sugiura Y, Kalo K, Nagai Y), Condensed heterocyclic compounds, their production and use. EP-00679642 (1995).
24. TAKEDA CHEMICAL INDUSTRIES LTD (Furuya S, Choh N, Harada M, Sasaki S), Thioenopyridine derivatives as gonadotropin releasing hormone antagonists. WO-09714697 (1997).